ASCO: No Benefit from Avastin in Glioblastoma

ASCO: No Benefit from Avastin in Glioblastoma. Patients with newly diagnosed glioblastoma lived no longer with the addition of bevacizumab (Avastin) to chemoradiation than they did without it, results of a large multicenter trial showed.

SOURCE: Gilbert MR, et al “RTOG 0825: Phase III double-blind, placebo-controlled trial evaluating bevacizumab in patients with newly diagnosed glioblastoma” ASCO 2013; Abstract 1.

You Might Also Enjoy...

INI Welcomes Dr. Ye

Dr. Ye Obtained his Medical Degree from Cleveland Clinic's prestigious College of Medicine at Case Western Reserve and continued his Neurosurgical training at Thomas Jefferson University Hospital in Philadelphia.

INI Welcomes Dr. Richard Young

He is a fellowship trained neurosurgeon sub-specializing in Neurointerventional/Neuroendovascular Surgery. He is uniquely able to assess and treat strokes, aneurysms, ArterioVenous Malformations (AVM), and vascular lesions with both...

INI Welcomes Dr. Siraj Gibani

INI welcomes Siraj Gibani. He is a fellowship trained neurosurgeon specializing in minimally invasive and complex spine surgery. His addition to the INI is part of the groups continued dedication to bring excellent neurosurgical care to the region.